此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

机器人辅助与传统膝关节内假体技术 (ROCKETS)

2026年9月16日 更新者:Olof Skoldenberg、Danderyd Hospital

ROCKETS:随机、多中心、偏好容忍研究中机器人辅助与传统膝关节内假体技术的比较

Rationale for conducting the study:

The ROCKET study evaluates the clinical and economic outcomes of robot-assisted total knee arthroplasty (RTKR) compared with conventional total knee arthroplasty (TKR). The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Secondary outcomes include patient-reported knee function, health-related quality of life, self-reported instability, physical activity, radiographic alignment, surgical and technical outcomes, complications, reoperations, revisions, and health-economic outcomes.

Study design:

International multicentre, preference-tolerant, randomized, controlled superiority trial with two treatment arms comparing RTKR with conventional TKR. Participants in the randomized part are allocated 1:1. At selected centres where feasible, an optional participant-blinded randomized component may be implemented. Eligible patients who do not undergo randomization may participate in a parallel observational/preference cohort, which is analysed separately from the primary randomized comparison.

Study population:

Adults aged 18 years and older who are eligible for total knee arthroplasty according to local guidelines and who provide informed consent.

Number of patients:

Up to 1,600 randomized participants. Eligible non-randomized participants may additionally be included in the observational/preference cohort.

Primary outcome:

Proportion of randomized participants achieving FJS ≥80 points at 24 months after surgery.

Long-term follow-up:

Patient-reported and registry-based outcomes are planned at 5 and 10 years after surgery where feasible.

研究概览

详细说明

The ROCKET study is an international multicentre, prospective, preference-tolerant randomized controlled superiority trial comparing robot-assisted total knee arthroplasty with conventional total knee arthroplasty.

Participants in the randomized component are allocated 1:1 to robot-assisted or conventional total knee arthroplasty. Randomization is stratified by participating centre and sex. At selected centres where practical and approved, participants may remain blinded to treatment allocation until completion of the 24-month follow-up unless earlier unblinding is clinically required or requested by the participant. Surgeons and operating-room personnel cannot be blinded. Outcome assessment is performed blinded to treatment allocation whenever feasible.

Eligible patients who are unwilling to undergo randomization, or for whom treatment equipoise cannot be achieved, may enter a parallel observational/preference cohort. Treatment in this cohort follows patient and surgeon preference. The observational/preference cohort is analysed separately from the primary randomized comparison.

The primary endpoint is the proportion of randomized participants achieving a Forgotten Joint Score (FJS) of ≥80 points at 24 months after surgery. Follow-up includes patient-reported outcomes, activity, radiographic alignment, surgical and technical variables, complications, reoperations, revisions and health-economic outcomes. Long-term follow-up is planned at 5 and 10 years after surgery, including PROMs where available and registry-based outcomes such as reoperations, revisions, complications and mortality.

研究类型

介入性

注册 (估计的)

1600

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Hässleholm、瑞典、281 38
        • 招聘中
        • Hässleholm Hospital
      • Stockholm、瑞典、182 88
        • 招聘中
        • Danderyd Hospital
        • 接触:
        • 首席研究员:
          • Olof Skoldenberg, MD, PhD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Adults aged 18 years and older.
  • Eligible for total knee arthroplasty according to local guidelines and routines.
  • Willingness to participate in the study.

Exclusion Criteria:

  • Patients with extreme malalignment necessitating special implants or techniques.
  • Patients unfit for surgery due to other medical reasons.
  • Patients who, for other reasons such as alcohol or substance abuse, are deemed unsuitable to participate in the study.
  • Patients who, for other reasons, cannot fulfil the required patient-reported outcome measures.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:RTKR

Robot-assisted total knee arthroplasty (RTKR).

Robot-assisted total knee arthroplasty using an approved robotic surgical system to assist intraoperative planning, bone preparation, implant positioning and balancing according to the participating centre's approved technique.

有源比较器:TKR

Conventional total knee arthroplasty (TKR).

Conventional total knee arthroplasty using standard manual instrumentation according to local clinical routine.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Proportion of participants achieving a Forgotten Joint Score (FJS) ≥80 points
大体时间:24 months after surgery

The primary endpoint is the proportion of randomized participants achieving an FJS of ≥80 points at 24 months after surgery. The FJS ranges from 0 to 100, with higher scores indicating less awareness of the replaced knee during everyday activities.

24 months after surgery

次要结果测量

结果测量
措施说明
大体时间
Forgotten Joint Score (FJS), continuous score
大体时间:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

FJS is scored from 0 to 100, with higher scores indicating less awareness of the replaced knee.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Knee injury and Osteoarthritis Outcome Score (KOOS)
大体时间:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

KOOS assesses knee-related pain, symptoms, activities of daily living, sport/recreation and knee-related quality of life. Each subscale ranges from 0 to 100, with higher scores indicating better outcome.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Self-reported knee instability (ADLS items)
大体时间:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

Self-reported slipping/partial giving way and buckling/full giving way are assessed using items from the Activities of Daily Living Scale of the Knee Outcome Survey.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
EQ-5D and EQ VAS
大体时间:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

Health-related quality of life is assessed using EQ-5D and EQ VAS.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Patient activity and walking distance
大体时间:Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery

Patient activity and walking distance are assessed during follow-up using the study's prespecified activity measurements.

Baseline, 6 weeks, 12 months, 24 months, 5 years and 10 years after surgery
Knee alignment
大体时间:Preoperative and approximately 6 weeks after surgery

Coronal knee alignment is assessed using long-standing radiographs, including Hip-Knee-Ankle alignment and Coronal Plane Alignment of the Knee (CPAK) classification.

Preoperative and approximately 6 weeks after surgery
Surgery time
大体时间:During the index operation

Duration of the surgical procedure is recorded in minutes.

During the index operation
Technical and intraoperative surgical outcomes
大体时间:During the index operation

Technical difficulties and prespecified intraoperative surgical details are recorded.

During the index operation
Range of motion (ROM)
大体时间:24 months after surgery

Knee range of motion is assessed at the 24-month follow-up.

24 months after surgery
Reoperations and revisions
大体时间:Up to 24 months, with additional follow-up at 5 and 10 years

Reoperations and revisions of the index knee are recorded during the primary study period and assessed during long-term follow-up where data are available.

Up to 24 months, with additional follow-up at 5 and 10 years
Adverse events and complications
大体时间:Up to 24 months, with additional long-term assessment at 5 and 10 years

Adverse events and complications related to the index knee arthroplasty are recorded. Long-term complications may additionally be assessed using approved registry or other data sources.

Up to 24 months, with additional long-term assessment at 5 and 10 years
Mortality
大体时间:90 days, 1 year, 5 years and 10 years after surgery

Mortality is assessed using available approved registry or other data sources.

90 days, 1 year, 5 years and 10 years after surgery
Health-economic outcomes
大体时间:Up to 24 months; exploratory long-term analyses at 5 and 10 years where data are available

Health-economic analyses include direct and indirect costs and cost-effectiveness using health-related quality-of-life data.

Up to 24 months; exploratory long-term analyses at 5 and 10 years where data are available

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年3月4日

初级完成 (估计的)

2029年12月1日

研究完成 (估计的)

2037年12月1日

研究注册日期

首次提交

2024年4月4日

首先提交符合 QC 标准的

2024年4月26日

首次发布 (实际的)

2024年4月29日

研究记录更新

最后更新发布 (实际的)

2026年9月21日

上次提交的符合 QC 标准的更新

2026年9月16日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2024DS
  • Knee (其他标识符:Danderyds sjukhus)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅